BioSig Technologies, Inc. Quarterly Debt-to-equity in % from Q3 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
BioSig Technologies, Inc. quarterly Debt-to-equity history and growth rate from Q3 2019 to Q3 2024.
  • BioSig Technologies, Inc. Debt-to-equity for the quarter ending September 30, 2024 was -196 %, a 118% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -196 -1.26K -118% Sep 30, 2024
Q2 2024 -207 -519 -166% Jun 30, 2024
Q1 2024 -220 -334 -294% Mar 31, 2024
Q4 2023 -795 -862 -1286% Dec 31, 2023
Q3 2023 1.07K +1.03K +2694% Sep 30, 2023
Q2 2023 312 +287 +1167% Jun 30, 2023
Q1 2023 114 +90.8 +396% Mar 31, 2023
Q4 2022 67 +46.4 +224% Dec 31, 2022
Q3 2022 38.2 +18 +88.9% Sep 30, 2022
Q2 2022 24.6 Jun 30, 2022
Q1 2022 23 Mar 31, 2022
Q4 2021 20.7 Dec 31, 2021
Q3 2021 20.2 Sep 30, 2021
Q3 2019 16.6 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.